Search research articles
Contact Us
Filters
Showing results (11-20 of 53) with videos related to
Page
of 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1993
Follow-up report on the outcome of patients relapsing after autologous marrow transplantation for malignant lymphoma
C H Weaver, F Appelbaum, F B Petersen, et al.
Cancer Treatment and Research
|
January 1, 1995
High-dose chemotherapy and autologous stem cell transplantation for breast cancer
C H Weaver, R Birch, L S Schwartzberg, et al.
Bone Marrow Transplantation
|
May 1, 1996
High-dose chemotherapy and autologous peripheral blood progenitor cell transplant for the treatment of Hodgkin's disease
C H Weaver, L Schwartzberg, W Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Effect of CD34(+) cell dose on resource utilization in patients after high-dose chemotherapy with peripheral-blood stem-cell support
K A Schulman, R Birch, B Zhen, et al.
Seminars in Oncology
|
August 1, 1997
A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer
R Birch, C H Weaver, J D Hainsworth, et al.
American Journal of Clinical Oncology
|
August 26, 1998
A randomized trial of mobilization of peripheral blood stem cells with cyclophosphamide, etoposide, and granulocyte colony-stimulating factor with or without cisplatin in patients with malignant lymphoma receiving high-dose chemotherapy
C H Weaver, B Zhen, L Schwartzberg, et al.
Experimental Hematology
|
December 1, 1995
Immunocytochemical analysis of tumor cells in pre- and post-culture peripheral blood progenitor cell collections from breast cancer patients
A A Ross, M Loudovaris, B Hazelton, et al.
Blood
|
November 15, 1995
An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy
C H Weaver, B Hazelton, R Birch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2000
Randomized trial of filgrastim, sargramostim, or sequential sargramostim and filgrastim after myelosuppressive chemotherapy for the harvesting of peripheral-blood stem cells
C H Weaver, K A Schulman, B Wilson-Relyea, et al.
Bone Marrow Transplantation
|
March 24, 1998
High-dose chemotherapy with BUCY or BEAC and unpurged peripheral blood stem cell infusion in patients with low-grade non-Hodgkin's lymphoma
C H Weaver, L Schwartzberg, S Rhinehart, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 53) with videos related to
Sort By:
Page
of 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1993
Follow-up report on the outcome of patients relapsing after autologous marrow transplantation for malignant lymphoma
C H Weaver, F Appelbaum, F B Petersen, et al.
Cancer Treatment and Research
|
January 1, 1995
High-dose chemotherapy and autologous stem cell transplantation for breast cancer
C H Weaver, R Birch, L S Schwartzberg, et al.
Bone Marrow Transplantation
|
May 1, 1996
High-dose chemotherapy and autologous peripheral blood progenitor cell transplant for the treatment of Hodgkin's disease
C H Weaver, L Schwartzberg, W Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Effect of CD34(+) cell dose on resource utilization in patients after high-dose chemotherapy with peripheral-blood stem-cell support
K A Schulman, R Birch, B Zhen, et al.
Seminars in Oncology
|
August 1, 1997
A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer
R Birch, C H Weaver, J D Hainsworth, et al.
American Journal of Clinical Oncology
|
August 26, 1998
A randomized trial of mobilization of peripheral blood stem cells with cyclophosphamide, etoposide, and granulocyte colony-stimulating factor with or without cisplatin in patients with malignant lymphoma receiving high-dose chemotherapy
C H Weaver, B Zhen, L Schwartzberg, et al.
Experimental Hematology
|
December 1, 1995
Immunocytochemical analysis of tumor cells in pre- and post-culture peripheral blood progenitor cell collections from breast cancer patients
A A Ross, M Loudovaris, B Hazelton, et al.
Blood
|
November 15, 1995
An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy
C H Weaver, B Hazelton, R Birch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2000
Randomized trial of filgrastim, sargramostim, or sequential sargramostim and filgrastim after myelosuppressive chemotherapy for the harvesting of peripheral-blood stem cells
C H Weaver, K A Schulman, B Wilson-Relyea, et al.
Bone Marrow Transplantation
|
March 24, 1998
High-dose chemotherapy with BUCY or BEAC and unpurged peripheral blood stem cell infusion in patients with low-grade non-Hodgkin's lymphoma
C H Weaver, L Schwartzberg, S Rhinehart, et al.
Page
of 6